Background: Paraoxonases (PON) are members of an enzyme family involved in preventing low-density lipoprotein oxidation and therefore protecting against atherosclerotic plaque formation. Methods: We studied the Met55Leu and Gln192Arg PON1 polymorphisms in 712 patients (437 Caucasianand 275 African-Brazilians) who underwent coronary angiography. Results: Among Caucasian-Brazilians, the homozygous 55LeuLeu frequency was higher among patients with significant coronary artery disease (CAD, obstructive lesions G50%) than among lesion-free controls (51% vs. 30.3%; ps0.022) in females, but not in males. The Gln192Arg PON1 polymorphism was not associated with CAD, although 192GlnGln homozygotes presented lower high-density lipoprotein (HDL)-cholesterol (ps0.035) and higher triglyceride (ps0.012) levels than 192Arg allele carriers among Caucasian-Brazilian males, but not females. No other lipid-genotype association was detected. Multivariate logistic regression corrected for classic CAD risk factors shows that 55LeuLeu PON1 homozygotes were at increased CAD risk (odds ratio ORs2.852; ps0.003) and that this genotype interacted with gender in its association with CAD risk (ORs0.290; ps0.006) among Caucasian-Brazilians. Conclusions: This report shows that the 55LeuLeu PON1 genotype increases CAD risk among female
Atherosclerosis is characterized by lipid deposition on the inner layer of the arterial wall. Oxidized low-density lipoprotein (LDL) is the major source of lipids for foam cell formation during atherogenesis and higher levels of LDL are associated with high oxidative stress conditions (1, 2) . High-density lipoprotein (HDL) plays a key role in protecting LDL from oxidation, in part due to an esterase called paraoxonase 1 (PON1) associated with HDL particles that can hydrolyze specific oxidized lipids and lipoproteins (3, 4) . Direct evidence of its role in atherogenesis has come from PON1 and apolipoprotein E (apoE) gene double-knockout mice that presented higher lipid peroxidation levels and developed more atherosclerosis (5, 6) .
PON1 is member of the paraoxonase family that includes three isozymes. Their genes are clustered on chromosome 7 q 21.3-22.1 (7) . The PON1 gene has two widely investigated polymorphisms, Met55Leu and Gln192Arg, which have previously been associated with LDL anti-oxidation activity (8) and coronary artery disease (CAD) risk among Caucasians and Asians in some but not all studies wreviewed in (9) x.
The present study aimed to investigate Met55Leu and Gln192Arg PON1 polymorphisms and their associations with angiographically assessed CAD and lipid levels in Caucasian-and African-Brazilians.
A total of 712 patients (437 Caucasian-and 275 African-Brazilians), who had undergone coronary angiography at Santa Izabel Hospital in Salvador, Bahia state, in Northeastern Brazil, as previously described (10), were studied. Angiography had been recommended due to symptoms related to CAD, major angina. Of these, 268 individuals presented no visible coronary lesion on angiography and were taken as controls. Among these controls, none presented acute myocardial infarction, cerebral vascular infarction or transient ischemic attack. The other 444 individuals presented at least one obstructive lesion of G50% and were taken as CAD cases, 194 of whom also presented a previous history of myocardial infarction con- firmed by ECG and/or cardiac enzymes in their medical records. Patients provided a detailed medical history and underwent physical examination. Patients with blood pressure G140/90 mm Hg and/or taking anti-hypertensive medication were described as having hypertension. Diabetes mellitus was defined as fasting glucose level G7.0 mmol/L and/or when the patient was taking anti-diabetic medication. Smoking was defined as self-reported current or past smoking. Patients who had a first-degree relative who had had a myocardial infarct, sudden death and/or angina by the age of 55 years for male or 65 years for female were considered to have a positive early CAD family history. African-and Caucasian-Brazilians were classified according to skin pigmentation on the inner forearm and morphological facial characteristics, as previously reported and validated by classical genetic marks (11) . All individuals provided written informed consent approved by the Hospital Ethics Committee.
Blood samples were drawn for DNA extraction and biochemical analysis from subjects who had fasted for at least 12 h. A salting out procedure method was used for DNA extraction as previously reported (12) . The Met55Leu and Gln192Arg PON1 polymorphisms were detected using a mismatched primer set in a multiplex PCR adapted from Motti et al. (13) . The PCR product was digested with HinfI and the fragment bands were viewed after acrylamide gel electrophoresis and ethidium bromide staining. Total cholesterol, HDL-cholesterol and triglyceride levels were measured by enzymatic methods using commercial kits (Wiener Lab, Rosario, Argentina) on an autoanalyzer. LDL-cholesterol levels were calculated using the Friedwald formula (14) .
Allele frequencies were estimated by gene counting. The agreement of genotype frequencies with Hardy-Weinberg expectations was tested by a x 2 goodness-of-fit test using Arlequin Program, version 2.000 (15) . ANOVA or Student's t-test was used to compare quantitative variables between groups. The lipoprotein levels were log transformed to reach normal distribution before ANOVA or t-test analysis, but untransformed levels are presented in the Tables. Allele frequency differences between cases and controls were compared by Pearson x 2 test using the PEPI program, version 4.0 (16). Odds ratio (OR) estimates and multivariate logistic regression were performed using SPSS version 10 (SPSS Inc., Chicago, IL, USA). A p-value of -0.05 was considered statistically significant. Table 1 presents the clinical and demographic characteristics of CAD cases and controls. There was a higher prevalence of males, smokers, those with diabetes mellitus and early CAD family history, as well as those who had higher triglyceride and lower HDLcholesterol levels among CAD cases than controls. Cases and controls were similar with respect to hypertension, total and LDL-cholesterol levels. However, in the same age range, CAD cases were somewhat older (55.5 years) than controls (52.3 years), and there was a lower frequency of African-Brazilians among cases compared to controls.
The Gln192Arg and Met55Leu PON1 genotype frequencies differed between Caucasian-and AfricanBrazilians. The 192ArgArg homozygous frequency was higher, while the 55MetMet genotype frequency was lower among African-Brazilians (28% and 16.7%, respectively) compared to Caucasian-Brazilians (17.8%, ps0.002 and 26.3%, ps0.010, respectively). Among the control group, the genotype frequencies were in accordance with those expected by HardyWeinberg equilibrium, except for the Met55Leu variant in Caucasian-Brazilian males, which showed deviation from equilibrium due to a lower heterozygous frequency than expected. Table 2 presents Met55Leu and Gln192Arg PON1 genotype frequencies in CAD cases and controls according to ethnic and gender groups. In CaucasianBrazilians, the 55LeuLeu genotype frequency was higher in CAD cases (51%) compared to controls (30.3%; ps0.022) in females, but not males. Among African-Brazilians, the Met55Leu polymorphism was not associated with CAD. The Gln192Arg PON1 genotype frequencies were not associated with CAD in African-and Caucasian-Brazilians for both male and female subjects (Table 2) . Table 3 presents the triglyceride and HDL-cholesterol levels among Gln192Arg PON1 genotypes in the total sample of cases and controls according to gender and ethnic group. Among Caucasian-Brazilians, 192GlnGln PON1 homozygotes presented the highest Results are for cases and controls combined.
triglyceride (ps0.012) and lowest HDL-cholesterol levels (ps0.035) in males, but not in females. In African-Brazilians, this polymorphism was not associated with differences in lipid levels. No other lipoprotein associations were detected with Gln192Arg PON1 genotypes and no lipid association at all was observed for Leu55Met PON1 genotypes (data not shown). Table 4 shows the multivariate logistic regression analyses for CAD risk among Caucasian-Brazilians. 55LeuLeu PON1 homozygotes were at increased CAD risk (ORs2.852; ps0.003) and there was a significant interaction between this genotype and gender (ORs0.290; ps0.008). These effects were independent and corrected for other classic CAD risk factors included in the regression model. Gln192Arg PON1 genotypes and other gene-smoking or gene-gender interactions were not significant CAD predictors. Among African-Brazilians, none of the PON1 genotypes were significantly associated with CAD risk in the multivariate logistic regression, even after correcting for other CAD risk factors (data not shown).
This investigation of the effects of PON1 gene polymorphisms on angiographically assessed CAD in a multi-ethnic Brazilian population has shown that 55LeuLeu PON1 homozygotes were at greater CAD risk among Caucasian-Brazilians, irrespective of lipoprotein levels and other classic CAD risk factors, as shown by the multivariate logistic regression analysis. The present study corroborates a previous investigation in Southern Caucasian-Brazilians (17); however, it further demonstrates that the 55LeuLeu effect on CAD risk is influenced by gender in our population. The Met55Leu and Gln192Arg PON1 polymorphism frequencies among African-and Caucasian-Brazilians were similar to those previously reported in related ethnic Brazilian populations from the Southern region (17, 18) , except for the 55Met allele frequency, which was higher than those previously reported for African-Brazilians from this region (18) . Ancestral African origins vary among African-Brazilians according to region (19) , which could explain this difference. The Met55Leu genotype frequencies were not those expected by Hardy-Weinberg equilibrium in Caucasian-Brazilian males. It is unlikely that genotyping errors could be the cause of this deviation, since we confirmed the genotyping, and the deviation is due to an excess of homozygous and not heterozygous genotypes, as expected for this type of error. It is more likely that the association of the 55LeuLeu homozygous genotype with CAD could lead to deviation of the homozygous genotype frequencies from Hardy-Weinberg equilibrium.
The only previous study (20) of Gln192Arg and Met55Leu PON1 polymorphism effects on angiographically assessed CAD in African-Americans showed no genotype association with this disease. Among Caucasian and Asian populations, 192Arg and/or 55Leu PON1 variants were positively associated with increased CAD risk in some (17, (21) (22) (23) (24) (25) , but not all studies (26) (27) (28) . The present report corroborates a positive association between 55LeuLeu PON1 and CAD risk in females, supporting a gender-specific interaction. The exact cause of this PON1 gender-specific effect on CAD is not known, although a PON1 genotype effect on carotid atherosclerosis in females, but not in males, has previously been demonstrated (29) . It is possible that hormonal differences between genders could influence lipoprotein oxidation and therefore the PON1 effect on atherosclerosis (30).
Smoking did not seem to be the cause of this genotype gender-specific effect, since the 55LeuLeu= smoking interaction was not a significant CAD predictor in the multivariate logistic model. Furthermore, as HDL and PON1 synthesis are highly correlated (31) and this HDL production is clearly influenced by steroid hormones (32) , it is possible that the PON1 genotype gender-specific effects could be, at least in part, indirectly explained by hormonal influences on HDL synthesis.
Although not associated with CAD, 192GlnGln PON1 homozygotes presented lower HDL-cholesterol and higher triglyceride levels among Caucasian-Brazilian males, as previously reported in CaucasianAmericans (29) . The adverse lipoprotein profile for the 192GlnGln PON1 genotype contrasts with its high enzyme activity in preventing LDL oxidation (8), which could be a possible explanation for the lack of association with CAD shown in the present study.
In summary, this study on angiographically assessed CAD in a multi-ethnic Brazilian sample demonstrates that 55LeuLeu PON1 homozygotes are at increased CAD risk among Caucasian-but not AfricanBrazilians, and this effect is influenced by gender, being more significant among females. Subjects homozygous for 192GlnGln PON1 had lower HDLcholesterol and higher triglyceride levels in Caucasian-Brazilian males, but this genotype was not associated with CAD risk.
